Portugal spent over a million euros on Mounjaro in a single day. That is more than 3,000 pens
Consultancy HMR - Health Market Research says Portuguese pharmacies sold more than 3,000 boxes of the weight-loss drug in one day, the third time the one-million-euro mark has been hit since August.
Portugal had already crossed the one-million-euro mark for Mounjaro sales in a single day twice, back in August. It happened again this week. Portuguese pharmacies sold more than 3,000 boxes of the weight-loss drug in one day, according to consultancy HMR - Health Market Research, which tracks sales across more than 2,600 pharmacies and posted the figure on social media. It isn’t a one-off. It’s the third time since summer.
Nobody else is picking up the bill
Each box costs between 180 and 400 euros, depending on the weekly dose. Mounjaro isn’t reimbursed in Portugal, and it’s sold on prescription only. So this week’s million came straight out of patients’ pockets, at a moment when Portuguese households are already stretched elsewhere: mortgage payments keep climbing, and the state’s own accounts slipped back into deficit in the first half of the year.
From diabetes drug to best-seller
Tirzepatide, Mounjaro’s active ingredient, is approved in Europe for type 2 diabetes and for weight management in adults with obesity or overweight. It reached Portuguese pharmacies at the end of 2024 and has since become the country’s best-selling obesity drug, following the path Ozempic and Wegovy opened before it.
The yearly numbers were already pointing this way. Portugal sold more than 572,000 packs of obesity drugs in 2025, almost five times the year before (a 378% jump). In May, Infarmed data put average spending at around 613,000 euros a day in the first quarter, for Mounjaro and Wegovy combined. A single day of just one of those drugs now tops a million. That’s a peak, not an average, but it shows which way the curve is heading.
There’s no sign of a slowdown. Until weight-loss treatment gets any state support, the price stays exactly where it is, and going by this week’s numbers, Portuguese patients are still willing to pay it.
By Beatriz Mota
Image: Raimond Spekking / Wikimedia Commons (CC BY-SA 4.0)